(Date:11/6/2009)...AYWARD, Calif., Nov. 6 Intarcia Th... on its ITCA 650 (DUROS® continuous delivery ...diabetes at the Ninth Annual Diabetes Technology M...www.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ...atide Via ITCA 650 Lowers Plasma Glucose, HbA1c an...
(Date:11/5/2009)...ELLINGTON, Colo., Nov. 5 The endan...ns in the western U.S. This rare carnivore feeds ...ptible to plague and often entire population die-o...Service (FWS) has implemented a ferret breeding pr...ets into their formerly native habitat. Unfortuna...
(Date:11/5/2009)...onference Call on Thursday, November 5, 2009 at 4:...VER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Phar...NASDAQ: OGXI ) today reported unaudited financial...ed September 30, 2009 and reviewed the Company,s h... following consolidated results reflect the operat...
(Date:11/5/2009)...ORT WORTH, Texas, Nov. 5 ...unced today that it has entered into a Letter of I... Virtual Health Technologies, Inc. (OTC Bulletin B... $1,000,000 in cash and debt, 4,000,000 shares of ...d by WNDM on the Veriscrip technology being acquir...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3...ife,s Clinical Flexibility, Expanding Physicians ...Cancer, SUNNYVALE, Calif., April 8, 2008 Accuray... the field of radiosurgery,announced today that a ...ational Journal of Radiation Oncology*Biology*Phys...es that the CyberKnife(R) Robotic,Radiosurgery Sys...
...oard of Molecular Vision today,announces that disc...tion,of Molecular Vision have now ceased. Acrongen... timetable agreed. Given this, the Board of,Molecu... company are served,by bringing these discussions ...nt shareholder in Molecular Vision, having recentl...
..., 2008 Martek,Biosciences Corporation announced t... District of Maryland has entered a Final Judgment...f the consolidated class action,brought on behalf ... class,action was brought under the federal securi...r things, of violations of Section 10(b) and 20(a)...
Other Biology Technology:CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 2CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 3CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 4Martek Announces Final Judgment and Order of Dismissal in Class Action 2...), fosmid (40kb), and large plasmid insert (10-20k...C vector. On command 20-50 fold copy amplification...tion. Available with blue-white screening (pEZ BAC...e highest insert stability. Kits include electroco...
Goat Anti-MAGP-2 (C-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...ynthetic peptide derived from the C-terminal regio...fic for the junctophilin-2 protein. Reactivity: M...ogenates frozen mouse skeletal muscle tissues). A...(froz) ImmunofluorescenceStorage: Store at -20C fo...
Mouse Anti-TGF-beta 2 Monoclonal Antibody, Unconjugated, Clone 8607 from R&D Systems
Biology Products: